Exclusion of Htra2-β1, an up-regulator of full-length SMN2 transcript, as a modifying gene for spinal muscular atrophy

Human Genetics

Volumn 107, Issue 6, 2000, Pages 554-558

  Helmken, C ^a   Wirth, B ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; EXON; GENE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOLECULAR GENETICS; MOLECULAR INTERACTION; MOTONEURON; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; SPINAL MUSCULAR ATROPHY; GENETICS;

ISOPROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SFRS10 PROTEIN, HUMAN;

HUMANS; MUSCULAR ATROPHY, SPINAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; PROTEIN ISOFORMS; RNA-BINDING PROTEINS; VARIATION (GENETICS);

EID: 0034353187     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390000409     Document Type: Article

References (31)

1. Sex in flies: The splice of life
2. Presymptomatic diagnosis of spinal muscular atrophy (SMA) III confirmed by deletion analysis of survival motor neuron gene
3. When is a deletion not a deletion? When it is converted
4. Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotypes
5. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy
6. The survival motor neuron protein in spinal muscular atrophy
7. A human homologue of the Drosophila sex determination factor transformer-2 has conserved splicing regulatory functions
8. Differential SMN2 expression associated with SMA severity
9. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: Evidence of deletion of the SMN gene in unaffected individuals
10. An essential SMN interacting protein (SIP1) is not involved in the phenotypic variability of spinal muscular atrophy (SMA)
11. Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)
12. A mouse model for spinal muscular atrophy
13. Identification and characterization of the spinal muscular atrophy determining gene
14. Correlation between severity and SMN protein level in spinal muscular atrophy
15. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
16. SMN oligomerization defect correlates with spinal muscular atrophy severity
17. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
18. Spinal muscular atrophy. Incidence in Iceland
19. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNt and SMNc gene copy number
20. A simple salting out procedure for extracting DNA from human nucleated cells
21. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2
22. -/- mice and results in a mouse with spinal muscular atrophy
23. Meeting report: International SMA Consortium Meeting
24. Human transformer-2-beta gene (SFRS 10): Complete nucleotide sequence, chromosomal location, and generation of tissue-specific isoform
25. Classification of spinal muscular atrophies
26. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing
27. Characterization of survival motor neuron (SMNt) gene deletions in asymptomatic carriers of spinal muscular atrophy
28. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)
29. Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: Association of marker genotype to disease severity and candidate cDNAs
30. Quantitative analysis of survival motor neuron copies: Identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implication for genetic counseling
31. Natural history in proximal spinal muscular atrophy (SMA): Clinical analysis of 445 patients and suggestions for a modification of existing classifications